Provided by Tiger Fintech (Singapore) Pte. Ltd.

Theravance Biopharma

11.23
-0.1200-1.06%
Volume:146.14K
Turnover:1.64M
Market Cap:561.51M
PE:-9.47
High:11.39
Open:11.32
Low:11.16
Close:11.35
Loading ...
Feb 24, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 18, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Feb 13, 2020

Major Issues Report

Current report, items 1.01, 2.02, 8.01, and 9.01
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 06, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 30, 2020

Major Issues Report

Current report, item 5.02
Jan 28, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jan 13, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Jan 08, 2020

Major Issues Report

Current report, item 8.01
Dec 26, 2019

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
Dec 04, 2019

Major Issues Report

Current report, items 1.01 and 9.01
Nov 08, 2019

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Nov 08, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 05, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Oct 29, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Sep 30, 2019

Major Issues Report

Current report, item 8.01
Sep 09, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Sep 04, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Aug 05, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]